Three experts in firearm violence and injury intervention and prevention—Emmy Betz, MD, MPH; Fatimah L. Dreier, MSc, MBA; and Joseph V. Sakran, MD, MPA, MPH—will discuss how doctors and policymakers can help minimize gun violence through advocacy and other actions.
Terri A. Laguna, MD, MSc, and other experts will unveil findings from a recent ATS diversity, equity, and inclusion survey that highlights the importance of a diverse workforce and how it contributes to improved outcomes for patients.
Three years after its emergence, SARS-CoV-2 continues to affect communities around the world. Lael Yonker, MD, previews an expert discussion on identifying and treating COVID-19 and the long-term impact of the disease across the lifespan.
The COVID-19 pandemic brought many unanswered questions and uncertainty about the effects of long COVID. Frits Franssen, MD, PhD, will chair a symposium that will explore COVID recovery treatments and whether pulmonary rehabilitation or natural recovery is more effective.
Tuesday’s session will discuss the identification and management of opportunistic infectious pathogens in the ICU. Co-chairs Edward Kilb, MD, and Diana Kelm, MD, ATSF, preview what to expect.
Participants in the Tuskegee Experiment were intentionally misinformed, and effective medication was withheld despite being available. Panelists will share insights about this medical breach of ethics and examine lessons learned to avoid similar missteps in research, said session Co-chair Maroun Matta, MD.
Patients who rely on medical oxygen are often provided the cheapest option for the medical equipment company rather than the best option, said Nicholas Kolaitis, MD, MS. He is part of a panel on the potential of clinician advocacy to effect change to improve the quality of life for these patients.
The Clinical Year in Review will continue with the third of four sessions highlighting the most impactful papers across pulmonary, critical care, and sleep medicine. Michelle Sharp, MD, MHS, and other experts will discuss recent literature in asthma, sarcoidosis, sepsis, and sleep disorders.
Eliseo J. Pérez-Stable, MD, identified the adverse effects of health disparities and outlined how science can provide the best defense against these imbalances. Engaging the community and standardizing the measurement of social and demographic factors that affect health are all part of the equation too.
Horace Delisser, MD, brought his message of hopeful awareness to the attendees of the ATS Diversity Forum. “DEI is under assault in the wider society and in medicine,” he said. He offered a framework for researchers and providers to reclaim DEI in the name of excellence.
The ATS Drug/Device, Discovery and Development Committee will host its ninth annual BEAR Cage competition, where three finalists will share their research findings and inventive ideas for judges. This year’s BEAR Cage finalists are Marco Almeda, MD, Ananth Charya, MD, MS, and Sreyankar Nandy, PhD.
Upcoming Industry Programs